SCHEMBL29348385

SCHEMBL29348385

Cn1ccc(COc2ccc(-c3ccc(Cl)c(C4CCC(O)NC4=O)c3)c(Cl)c2)n1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 17/20 0.38
JAK2 O60674 1/20 0.37
GRM2 Q14416 1/20 0.34
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29348288 0.85 CRBN (0.44) ALOX5APJAK2KCNH2
SCHEMBL29348378 0.83 JAK2 (0.40) ALOX5APJAK2GRM2
SCHEMBL29348384 0.79 CRBN (0.43) ALOX5APJAK2
SCHEMBL29348382 0.78 JAK2 (0.43) ALOX5APJAK2GRM2
SCHEMBL29348408 0.71 CRBN (0.44) ALOX5APJAK2
SCHEMBL29348407 0.70 PDCD1 (0.33) JAK2GRM2KCNH2
SCHEMBL29348423 0.70 NR1I2 (0.35) JAK2GRM2KCNH2
SCHEMBL31068277 0.68 CRBN (0.46) JAK2GRM2
SCHEMBL31068109 0.66 CRBN (0.46) JAK2
SCHEMBL31068149 0.66 CRBN (0.46) JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151547-A1 TARGETED DEGRADATION OF VAV1 MONTE ROSA THERAPEUTICS, INC. (US) 2024-07-18 WO disclosed